Pharma Co. Gets Investor Suit Over New Diazepam Drug Axed
A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading...To view the full article, register now.
Already a subscriber? Click here to view full article